Therapeutics Advances
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Surg Proced. Nov 28, 2015; 5(3): 217-222
Published online Nov 28, 2015. doi: 10.5412/wjsp.v5.i3.217
Versatility of therapeutic reduction mammoplasty in oncoplastic breast conserving surgery
Fernando Hernanz, Mónica González-Noriega, Rocío Vázquez Pérez, Manuel Gómez-Fleitas
Fernando Hernanz, Mónica González-Noriega, Rocío Vázquez Pérez, Manuel Gómez-Fleitas, Department of Surgery, Valdecilla Hospital, 39008 Santander, Cantabria, Spain
Author contributions: Hernanz F contributed to the conception and design of the study, who carried out surgical procedures; González-Noriega M made acquisition of and analysis and interpretation of them; Pérez RV made acquisition of data; Gómez-Fleitas M made critical revision.
Conflict-of-interest statement: All authors disclose that they do not have any commercial associations or financial support.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Fernando Hernanz, MD, PhD, Assistant Professor of Surgery, Department of Surgery, Valdecilla Hospital, Avenue Valdecilla sn., 39008 Santander, Cantabria, Spain. cgdhff@humv.es
Telephone: +34-942-203733 Fax: +34-942-202726
Received: February 28, 2015
Peer-review started: March 2, 2015
First decision: June 3, 2015
Revised: June 27, 2015
Accepted: July 21, 2015
Article in press: July 23, 2015
Published online: November 28, 2015
Abstract

Oncoplastic breast conserving surgery is the gold standard approach for the surgical treatment of early breast cancer. There is a well defined technique named “therapeutic mammoplasty” which is characterized for using a reduction mammaplasty technique to treat breast cancer conservatively. In our current practice, “therapeutic mammoplasty” or therapeutic reduction mammaplasty is our favorite oncoplastic breast conserving approach which it used in almost half of our patients. This technique is very versatile allows us the resection of tumors located in all breast quadrants of patients with moderate-to large-sized breasts. We describe a series of 57 patients who were treated using a therapeutic reduction mammaplasty. All surgical procedures were carried out by one comprehensive breast surgeon who planned and designed the surgery performing both oncologic and reconstructive procedures. Surgical margins were insufficient in eight patients (14%). Nine patients (15.8%) had a complication in early postoperative period and in one of them adjuvant radiotherapy was delayed four months due to a wound dehiscence. The rate of synchronous contralateral symmetrization was 31.6%. Our conclusion is that reduction mammaplasty is a useful and safe skill to treat breast cancer conservatively playing a very important role therefore it must be situated in the priority of learning objectives.

Keywords: Breast conserving surgery, Oncoplastic, Oncoplastic breast surgery, Reduction mammoplasty, Therapeutic mammaplasty

Core tip: Reduction mammaplasty techniques are a really useful and safe skills to treat breast cancer conservatively allowing breast surgeons manage tumors located in all breast quadrants with low morbidity in moderate to large breasted patients, thanks their versatility they play a very important role in oncoplastic conservative surgery therefore they must be situated in the priority of learning objectives.